Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for PLEGRIDY
- A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis
- Study to Evaluate the Efficacy and Safety of Dimethyl Fumarate (Tecfidera) and Peginterferon Beta-1a (Plegridy) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Pediatric Participants
- Evaluating the Use of Prednisone to Decrease Pegylated Interferon Beta-1a Side Effects
- Evaluate Safety/Tolerability in Portuguese Participants With RRMS Transitioning From Current Therapy
- Single Center, Open Label, Study of Preparation H on Erythema in Relapsing MS Patients Treated With PLEGRIDY
- Plegridy Satisfaction Study in Participants
- Brimonidine Tartrate for the Treatment of Injection Related Erythema
- Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif® (Interferon Beta-1a) in Healthy Volunteers
- Plegridy Observational Program
- Characterize Flu-like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning From Non-Pegylated Interferon Beta (IFN-β) Therapies to Peginterferon Beta-1a (BIIB017)
- Biogen Multiple Sclerosis Pregnancy Exposure Registry
- Long-Term Safety and Efficacy Study of Peginterferon Beta-1a
- Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis
Clinical trials list
click for details